Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005843 · ClinicalTrials.gov registry record · Phase 2

R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer

A Phase 2 study of Pancreatic Cancer, sponsored by National Cancer Institute (NCI).

Completed
Registry status
Phase 2
Development phase
40
Enrollment target
2
Study locations

NCT00005843 is a Phase 2 study of Pancreatic Cancer that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 40 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005843, a Phase 2 study of Pancreatic Cancer, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
Phase 2
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

Phase II trial to study the effectiveness of R115777 in treating patients who have metastatic pancreatic cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Conditions Studied

Pancreatic Cancer

Interventions

  • DRUG tipifarnib

Study Locations (2)

Pennsylvania

  • Fox Chase Cancer Center - Philadelphia

Texas

  • University of Texas - MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2000-05
Phase Phase 2

Sponsor

National Cancer Institute (NCI)

3,257 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00005843

The ClinicalTrials.gov registry entry for NCT00005843 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (90% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancreatic Cancer appearing as the primary indexed condition, and to 1 intervention - of which tipifarnib is the first listed.

NCT00005843 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Texas.

Frequently Asked Questions

What is clinical trial NCT00005843 about?

NCT00005843 is a clinical study titled "R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer". Phase II trial to study the effectiveness of R115777 in treating patients who have metastatic pancreatic cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

What is the current status of trial NCT00005843?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2000-05.

What conditions does trial NCT00005843 study?

This clinical trial studies the following conditions: Pancreatic Cancer.

What interventions are being tested in trial NCT00005843?

The interventions under investigation include: tipifarnib (DRUG).

Who is sponsoring clinical trial NCT00005843?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00005843 being conducted?

This trial has 2 study locations across Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pancreatic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pancreatic Cancer

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.